

Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders. Among its major competitors, Ardelyx is ranked in 8th place for NPS while Aurinia Pharmaceuticals is 1st, and Genentech is 2nd.Their current market cap is $701.29M